David Krempa | SVP, Business Development and IR |
Sean Brynjelsen | CEO |
Wilson Troutman | CFO |
Paul Stickler | SVP, Sales and Marketing |
Andrew D’silva | B. Riley Securities |
Ram Selvaraju | H.C. Wainwright |
Good afternoon and welcome to the Eton Pharmaceuticals Second Quarter 2021 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode.
Following the formal remarks, we will open the call up for your questions. Please be advised that this call is being recorded at the Company’s request. At this time, I’d like to turn it over to David Krempa, Senior Vice President of Business Development and Investor Relations at Eton Pharmaceuticals.